<DOC>
	<DOCNO>NCT01108263</DOCNO>
	<brief_summary>- After determine subject meet criterion include study randomly place either Group 1 2 patient blind randomization group . - Subjects walk across pressure plate determine different area high pressure foot . This do INTEGRA application every follow-up visit . - Both group debrided picture take OR - Group 1 Integra Flowable Wound Matrix apply onto wound OR Group 2 Integra Flowable Wound Matrix apply onto wound inject subcutaneously OR . - Subjects place total contact cast visit . If wound healing occur prior 12 week , final assessment visit do status heal ulcer assess .</brief_summary>
	<brief_title>Use INTEGRA™ Flowable Wound Matrix Manage Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Subject 18 year age old 2 . Subjects plantar diabetic foot wound , without previous history partial foot amputation . 3 . Subject Diabetes Mellitus ( type 1 type 2 ) . 4 . University Texas Classification 1A wound area measurement range 0.34.0cm² . 5 . Ability willingness understand comply study procedure give write informed consent prior enrollment study . 1 . Subjects &lt; 18 year age 2 . Subject nondiabetic 3 . Subjects present wound etiology diabetes 4 . Subject demonstrates increase sign clinical infection 5 . Has active malignant disease kind . A subject , malignant disease past , treat currently diseasefree , may consider study entry . 6 . University Texas Classification great grade 1A 7 . Diabetic plantar foot wound measure &gt; 4.0cm² 8 . Subjects present significant vascular metabolic comorbidity would preclude wound heal 9 . Subjects participate trial regard diabetic foot ulcer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>